InVivo Therapeutics Corporation (NVIV) to Present at 5th Annual Biotech Showcase  
1/4/2013 6:19:28 AM

InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that Chief Executive Officer Frank Reynolds will present recent updates to potential investors during Biotech Showcase 2013. The annual conference is scheduled for January 7-9th at the Parc 55 Wyndham in San Francisco.